Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.smaller Cos. Regulatory News (BSV)

Share Price Information for Br.smaller Cos. (BSV)

Share Price is delayed by 15 minutes
Get Live Data
71.50    0.00 (0.00%)
Bid:
70.00
Ask:
73.00
Spread: 3.00 (4.286%)
Market Cap: £298.33m
BSV Live PriceLast checked at - London Stock Exchange

Intraday Br.smaller Cos. Share Chart

Statement re Net Asset Value and Fundraising

27 Aug 2021 15:15

RNS Number : 0692K
British Smaller Companies VCT PLC
27 August 2021
 

British Smaller Companies VCT plc ("the Company")

 

Statement re Net Asset Value and Proposed Fundraising

 

The Company announces that as at 30 June 2021 the unaudited net asset value of its ordinary shares was 88.2 pence per ordinary share, an increase of 12.4 pence per ordinary share (16.4 per cent) over the unaudited net asset value of the ordinary shares as at 31 March 2021. Following payment of the interim dividend of 2.0 pence per ordinary share for the year ending 31 March 2022 on 23 July 2021 the unaudited net asset value is 86.2 pence per ordinary share.

 

Despite a further national lockdown in the first quarter 0f 2021, the strong performance which saw 24.6 per cent growth in net asset value in the previous financial year has continued in the three months to 3o June 2021.

 

Further details of the Company's performance during the period will be included in the Company's unaudited interim management report for the three months ended 30 June 2021 which will be published before the end of September 2021.

 

Subsequent to 30 June 2021 the Company has exchanged contracts to realise a proportion of its investment in Matillion Limited ("Matillion"), as part of a wider fundraising by Matillion. In isolation, the unaudited impact on the Company's net asset value at 30 June 2021 of the proposed fundraising and the partial realisation is estimated to be a further increase of 1.8 pence per ordinary share. The completion of the transaction is subject to a regulatory clearance which is anticipated in the near future.

 

The additional increase of 1.8 pence per ordinary share over the unaudited net asset value of 88.2 pence per ordinary share from this partial realisation is in isolation from other changes in the Company's balance sheet since 30 June 2021.

 

Further to the announcement on 15 June 2021, it is anticipated that the Company's proposed Joint Fundraising with British Smaller Companies VCT2 plc in the 2021/22 tax year will open in the week commencing 20 September 2021, seeking to raise in aggregate £40 million, with an over allotment facility of £20 million. Further details of the Fundraising will be announced at the time of the launch.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the UK version of Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

For further information, please contact:

 

David Hall YFM Private Equity Limited Tel: 0113 244 1000

 

Alex Collins Panmure Gordon (UK) Limited Tel: 0207 886 2767

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRFLFISTIIDFIL
Date   Source Headline
11th Jun 202612:15 pmRNSAnnual Financial Report
20th Apr 202610:00 amRNSAdmission to Trading
1st Apr 20269:00 amRNSIssue of Equity
27th Mar 20264:10 pmRNSTransaction in Own Shares
23rd Mar 202610:45 amRNSPublication of a Supplementary Prospectus
19th Mar 20267:00 amRNS3rd Quarter Results
30th Jan 20267:00 amRNSAdmission of Further Securities to Trading
7th Jan 20269:30 amRNSIssue of Equity
23rd Dec 20258:54 amRNSAmendments to AIFM Agreements
23rd Dec 20258:54 amRNSAmendments to AIFM Agreements
22nd Dec 20259:13 amRNSTransaction in Own Shares
22nd Dec 20259:13 amRNSTransaction in Own Shares
19th Dec 202510:02 amRNSPayment of Dividend and Issue of Equity
19th Dec 202510:02 amRNSPayment of Dividend and Issue of Equity
18th Dec 202512:14 pmRNSClose of Offers to new Applications
18th Dec 202512:14 pmRNSClose of Offers to new Applications
28th Nov 202510:00 amRNSHalf-year Financial Report
20th Nov 20259:00 amRNSOffer Update
11th Nov 20257:00 amRNSDividend Declaration
27th Oct 202511:00 amRNSNominal Capital Reduction
10th Oct 20253:41 pmRNSOffer Update
2nd Oct 20259:00 amRNSOffer Update
25th Sep 20259:04 amRNSPublication of a Prospectus
23rd Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSInterim Management Statement
9th Sep 202512:56 pmRNSResult of AGM
22nd Aug 202510:45 amRNSNew combined offer for subscription
25th Jul 202510:16 amRNSPayment of dividend and issue of Equity
24th Jun 20257:00 amRNSTransaction in Own Shares
13th Jun 20251:30 pmRNSAnnual Financial Report
1st Apr 20258:02 amRNSDirector/PDMR Shareholding
1st Apr 20258:00 amRNSIssue of Equity
26th Mar 20255:13 pmRNSTransaction in Own Shares
24th Mar 202512:45 pmRNSPublication of Supplementary Prospectus
24th Mar 202512:45 pmRNSPublication of Supplementary Prospectus
18th Mar 20251:00 pmRNS3rd Quarter Results
30th Jan 20259:05 amRNSDirector/PDMR Shareholding
30th Jan 20259:00 amRNSIssue of Equity
27th Jan 20259:23 amRNSPayment of dividend and issue of shares
8th Jan 20252:14 pmRNSClose of Offer to new Applications
8th Jan 20252:13 pmRNSClose of Offer to new Applications
20th Dec 20249:26 amRNSPayment of dividend and issue of equity
17th Dec 20247:00 amRNSDividend Declaration
16th Dec 20245:09 pmRNSTransaction in Own Shares
29th Nov 20249:00 amRNSHalf-year Report
20th Nov 20241:00 pmRNSOffer Update
20th Nov 20241:00 pmRNSOffer Update
14th Nov 20247:48 amRNSDividend Declaration
1st Nov 20247:00 amRNSOffer Update
1st Nov 20247:00 amRNSOffer Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.